Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

RKDAArcadia Biosciences, Inc.

Nasdaq · CIK 0001469443
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2080 Beverages
FY end1231
XBRL facts439

Identity from submissions API

NameArcadia Biosciences, Inc.
CIK0001469443
TickersRKDA
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2080 Beverages
EIN810571538
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone214-974-8921
Website—
Investor website—
Owner org04 Manufacturing
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
5956 SHERRY LANE
SUITE 2000
DALLAS
TX
TX
Mailing address
5956 SHERRY LANE
SUITE 2000
DALLAS
TX
TX

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

599 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-005252 005-88855 261558077 34 10428
2026-11-12 10-Q 10-Q 0001193125-26-458412 001-37383 261547100 34 11647907 1 1
2026-11-12 8-K 8-K 2.02,9.01 0001193125-26-458371 001-37383 261546979 34 670586 1 1
2026-09-30 S-8 S-8 0001193125-26-409063 333-299214 261427302 33 293299 1 1
2026-09-30 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002103370-26-000004 005-88855 261425575 34 43612
2026-09-15 8-K 8-K 5.02,5.07,9.01 0001193125-26-391780 001-37383 261380521 34 788587 1 1
2026-09-14 4 4 0001193125-26-390532 5388
2026-09-14 4 4 0001193125-26-390528 5406
2026-09-14 4 4 0001193125-26-390521 5360
2026-09-14 4 4 0001193125-26-390520 5382
2026-09-04 8-K 8-K 3.01,9.01 0001193125-26-383642 001-37383 261362148 34 160535 1 1
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-003613 005-88855 261277295 34 10456
2026-08-13 10-Q 10-Q 0001193125-26-349205 001-37383 261273499 34 10642758 1 1
2026-08-13 8-K 8-K 2.02,9.01 0001193125-26-349180 001-37383 261273384 34 681596 1 1
2026-08-10 ARS ARS 0001193125-26-342445 001-37383 261258717 34 1044362
2026-08-10 DEF 14A DEF 14A 0001193125-26-342437 001-37383 261258683 34 5229708 1 1
2026-08-10 8-K 8-K 3.01,9.01 0001193125-26-340664 001-37383 261255757 34 154497 1 1
2026-07-31 PRE 14A PRE 14A 0001193125-26-328642 001-37383 261228842 34 3044304
2026-07-09 424B3 424B3 0001193125-26-298841 333-297072 261163583 33 178514
2026-07-08 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002229 333-297072 261163865 33 1732
2026-07-02 8-K 8-K 5.02,5.08,8.01 0001193125-26-294619 001-37383 261151610 34 219850 1 1
2026-06-26 D xslFormDX01/primary_doc.xml 06b 0001469443-26-000002 021-588846 261130142 33 10808
2026-06-26 S-3 S-3 0001193125-26-285578 333-297072 261129891 33 545544 1 1
2026-06-15 8-K 8-K 1.01,3.02,7.01,9.01 0001193125-26-270560 001-37383 261089638 34 1738062 1 1
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-002169 005-88855 26984277 34 10331
2026-05-14 10-Q 10-Q 0001193125-26-223990 001-37383 26978839 34 8722606 1 1
2026-05-14 8-K 8-K 2.02,9.01 0001193125-26-223985 001-37383 26978779 34 576208 1 1
2026-04-30 10-K/A 10-K/A 0001193125-26-197315 001-37383 26925520 34 2002986 1 1
2026-04-03 8-K 8-K 4.01,9.01 0001193125-26-142030 001-37383 26837899 34 173751 1 1
2026-03-26 10-K 10-K 0001193125-26-126238 001-37383 26798276 34 16040421 1 1
2026-03-26 8-K 8-K 2.02,9.01 0001193125-26-126220 001-37383 26798171 34 643518 1 1
2026-02-11 424B3 424B3 0001193125-26-045063 333-292993 26617691 33 210299
2026-02-10 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000515 333-292993 26618205 33 1731
2026-02-06 8-K 8-K 5.02,9.01 0001193125-26-041144 001-37383 26607541 34 146873 1 1
2026-02-05 CORRESP filename1.htm 0001193125-26-039882 14549
2026-02-05 UPLOAD filename1.pdf 0000000000-26-001260 333-292993 40064
2026-01-28 S-3 S-3 0001193125-26-025262 333-292993 26567899 33 786924 1 1
2026-01-27 CORRESP filename1.htm 0001193125-26-025264 9244
2026-01-27 D xslFormDX01/primary_doc.xml 06b 0001469443-26-000001 021-571201 26561606 33 12459
2026-01-20 RW RW 0001193125-26-015604 333-284972 26540867 NE 16840
2026-01-14 8-K 8-K 1.01,3.02,3.03,7.01,9.01 0001193125-26-012028 001-37383 26531236 34 769876 1 1
2025-12-29 425 425 0001193125-25-335432 001-37383 251609600 34 80481
2025-12-29 8-K 8-K 1.02,7.01,9.01 0001193125-25-335410 001-37383 251609564 34 220861 1 1
2025-12-23 8-K 8-K 5.07 0001193125-25-331009 001-37383 251601043 34 180089 1 1
2025-11-19 ARS ARS 0001193125-25-288191 001-37383 251499798 34 1413282
2025-11-19 DEF 14A DEF 14A 0001193125-25-288164 001-37383 251499728 34 3023367 1 1
2025-11-07 10-Q 10-Q 0001193125-25-272375 001-37383 251462833 34 11863693 1 1
2025-11-07 8-K 8-K 2.02,9.01 0001193125-25-272368 001-37383 251462790 34 811180 1 1
2025-10-24 8-K 8-K 5.08,8.01,9.01 0001193125-25-249854 001-37383 251415878 34 194628 1 1
2025-08-29 8-K 8-K 5.02,9.01 0000950170-25-112267 001-37383 251281869 34 164854 1 1
2025-08-19 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-110227 7016
2025-08-14 10-Q 10-Q 0000950170-25-109040 001-37383 251220743 34 11706673 1 1
2025-08-14 425 425 0000950170-25-108990 001-37383 251220077 34 607922
2025-08-14 8-K 8-K 2.02,9.01 0000950170-25-108983 001-37383 251220053 34 745087 1 1
2025-07-31 S-4/A S-4/A 0000950170-25-100440 333-284972 251168394 33 36282757 1 1
2025-05-16 8-K 8-K 7.01,8.01,9.01 0000950170-25-073711 001-37383 25960656 34 174218 1 1
2025-05-12 4 4 0000950170-25-069633 5458
2025-05-12 4 4 0000950170-25-069626 5466
2025-05-08 10-Q 10-Q 0000950170-25-066425 001-37383 25923995 34 10807683 1 1
2025-05-08 425 425 0000950170-25-066422 001-37383 25923990 34 491608
2025-05-08 8-K 8-K 2.02,9.01 0000950170-25-066420 001-37383 25923985 34 640821 1 1
2025-05-02 425 425 0000950170-25-062927 001-37383 25909912 34 81172 1 1
2025-05-02 8-K 8-K 1.01,9.01 0000950170-25-062913 001-37383 25909726 34 207053 1 1
2025-04-30 10-K/A 10-K/A 0000950170-25-061044 001-37383 25895074 34 2272403 1 1
2025-04-03 8-K 8-K 1.01,9.01 0000950170-25-050406 001-37383 25809661 34 156752 1 1
2025-03-25 10-K 10-K 0000950170-25-044487 001-37383 25768937 34 17267075 1 1
2025-03-20 8-K 8-K 2.02,9.01 0000950170-25-042647 001-37383 25756472 34 730298 1 1
2025-02-14 S-4 S-4 0000950170-25-021203 333-284972 25629019 33 33565865 1 1
2025-02-05 4 4 0000950170-25-014814 5385
2025-02-05 4 4 0000950170-25-014802 5395
2025-01-03 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001535610-25-000010 005-88855 25504743 34 9345
2024-12-11 425 425 0000950170-24-135479 001-37383 241542465 34 13225688
2024-12-11 8-K 8-K 7.01,9.01 0000950170-24-135447 001-37383 241542357 34 13358898 1 1
2024-12-06 425 425 0000950170-24-133818 001-37383 241530341 34 1130068
2024-12-06 8-K 8-K 1.01,5.01,5.02,7.01,9.01 0000950170-24-133817 001-37383 241530336 34 1385818 1 1
2024-11-22 S-8 S-8 0000950170-24-130137 333-283407 241489270 33 193580
2024-11-12 10-Q 10-Q 0000950170-24-125613 001-37383 241449567 34 12234622 1 1
2024-11-12 8-K 8-K 2.02,9.01 0000950170-24-125393 001-37383 241448194 34 633227 1 1
2024-08-23 8-K/A 8-K/A 5.02,9.01 0000950170-24-100065 001-37383 241234879 34 915064 1 1
2024-08-21 4 4 0000950170-24-099644 5301
2024-08-21 4 4 0000950170-24-099639 5273
2024-08-21 4 4 0000950170-24-099625 5295
2024-08-21 4 4 0000950170-24-099621 5285
2024-08-21 4 4 0000950170-24-099619 5310
2024-08-21 4 4 0000950170-24-099617 5319
2024-08-21 4 4 0000950170-24-099605 5481
2024-08-21 4 4 0000950170-24-099593 5489
2024-08-20 4 4 0000950170-24-099338 5357
2024-08-20 4 4 0000950170-24-099335 5365
2024-08-13 10-Q 10-Q 0000950170-24-096439 001-37383 241202977 34 12536855 1 1
2024-08-13 8-K 8-K 2.02,9.01 0000950170-24-096215 001-37383 241201563 34 637076 1 1
2024-08-07 8-K 8-K 5.02 0000950170-24-092432 001-37383 241182468 34 176714 1 1
2024-07-18 3 3 0000950170-24-084587 22107
2024-07-08 8-K 8-K 5.02 0000950170-24-082092 001-37383 241104830 34 290654 1 1
2024-07-01 8-K 8-K 5.07 0000950170-24-079602 001-37383 241090651 34 179485 1 1
2024-05-20 8-K 8-K 1.01,2.01,9.01 0000950170-24-062449 001-37383 24965115 34 1653437 1 1
2024-05-17 8-K 8-K 1.01,2.01,9.01 0000950170-24-061526 001-37383 24959220 34 705763 1 1
2024-05-16 DEFA14A DEFA14A 0000950170-24-060971 001-37383 24954692 34 1425573
2024-05-16 DEF 14A DEF 14A 0000950170-24-060967 001-37383 24954690 34 4329030 1 1
2024-05-13 10-Q 10-Q 0000950170-24-058563 001-37383 24938659 34 9612237 1 1
2024-05-09 8-K 8-K 2.02,9.01 0000950170-24-056928 001-37383 24930565 34 506376 1 1
2024-04-29 10-K/A 10-K/A 0000950170-24-049710 001-37383 24889424 34 1457562 1 1
2024-03-28 10-K 10-K 0000950170-24-038176 001-37383 24800489 34 15556348 1 1
2024-03-28 8-K 8-K 2.02,9.01 0000950170-24-038153 001-37383 24800163 34 588189 1 1
2024-02-14 8-K 8-K 5.02,9.01 0000950170-24-015228 001-37383 24638353 34 224064 1 1
2024-02-14 SC 13G/A armistice-rkda123123a1.htm 0001172661-24-001286 005-88855 24636398 34 90636
2024-02-05 4 4 0000950170-24-011271 5366
2024-01-03 SC 13G RKDA 13G 1.03.23 0001535610-24-000020 005-88855 24505149 34 13173
2023-11-09 10-Q 10-Q 0000950170-23-062216 001-37383 231393612 34 13966275 1 1
2023-11-09 8-K 8-K 2.02,9.01 0000950170-23-062038 001-37383 231392452 34 772875 1 1
2023-08-10 10-Q 10-Q 0000950170-23-041468 001-37383 231160579 34 13509264 1 1
2023-08-10 8-K 8-K 2.02,9.01 0000950170-23-041361 001-37383 231159789 34 873198 1 1
2023-08-07 4 FORM 4 SUBMISSION 0001209191-23-044889 5487
2023-07-20 8-K 8-K 2.02,8.01,9.01 0000950170-23-033652 001-37383 231099421 34 204378 1 1
2023-06-16 4 FORM 4 SUBMISSION 0001209191-23-037763 9747
2023-06-16 4 FORM 4 SUBMISSION 0001209191-23-037761 9750
2023-06-16 4 FORM 4 SUBMISSION 0001209191-23-037757 9770
2023-06-16 4 FORM 4 SUBMISSION 0001209191-23-037752 9738
2023-06-16 4 FORM 4 SUBMISSION 0001209191-23-037750 9779
2023-06-16 4 FORM 4 SUBMISSION 0001209191-23-037748 9779
2023-06-12 8-K 8-K 5.07 0000950170-23-027479 001-37383 231008180 34 203180 1 1
2023-05-30 4 FORM 4 SUBMISSION 0001209191-23-032996 5104
2023-05-25 S-8 S-8 0000950170-23-024236 333-272201 23960748 33 248403
2023-05-15 10-Q 10-Q 0000950170-23-022199 001-37383 23922222 34 12156838 1 1
2023-05-11 8-K 8-K 2.02,9.01 0000950170-23-021303 001-37383 23911466 34 309510 1 1
2023-04-28 4 FORM 4 SUBMISSION 0001209191-23-026082 9927
2023-04-28 4 FORM 4 SUBMISSION 0001209191-23-026080 9964
2023-04-28 4 FORM 4 SUBMISSION 0001209191-23-026079 9934
2023-04-25 DEFA14A DEFA14A 0000950170-23-014439 001-37383 23845048 34 1084754
2023-04-25 DEF 14A DEF 14A 0000950170-23-014433 001-37383 23845021 34 4973825 1 1
2023-04-18 424B3 424B3 0000950170-23-013137 333-271082 23825253 33 151459
2023-04-17 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-04-17 17:00:00 9999999995-23-000957 333-271082 23825401 33 1710
2023-04-13 CORRESP filename1.htm 0000950170-23-012709 14616
2023-04-13 10-K/A 10-K/A 0000950170-23-012708 001-37383 23818447 34 2160759 1 1
2023-04-10 UPLOAD filename1.pdf 0000000000-23-003546 40335
2023-04-03 CORRESP filename1.htm 0000950170-23-011622 11211
2023-04-03 S-3 S-3 0001564590-23-005206 333-271082 23792731 33 387104
2023-03-30 10-K 10-K 0000950170-23-011019 001-37383 23781653 34 19530427 1 1
2023-03-30 8-K 8-K 2.02,9.01 0000950170-23-010933 001-37383 23780713 34 809948 1 1
2023-03-03 424B3 424B3 0000950170-23-006026 333-267637 23705158 33 16437
2023-03-03 424B3 424B3 0000950170-23-006023 333-262407 23705131 33 16428
2023-03-03 424B3 424B3 0000950170-23-006022 333-252659 23705104 33 16426
2023-03-03 424B3 424B3 0000950170-23-006021 333-239641 23705068 33 16517
2023-03-03 424B3 424B3 0000950170-23-006019 333-235446 23704979 33 16428
2023-03-03 8-K 8-K 1.01,3.02,9.01 0000950170-23-006005 001-37383 23704180 34 1834217 1 1
2023-02-28 8-K 8-K 3.03,5.03,9.01 0000950170-23-005092 001-37383 23685411 34 213877 1 1
2023-02-22 8-K 8-K 5.07,9.01 0000950170-23-003754 001-37383 23653191 34 195224 1 1
2023-02-14 SC 13G armistice-rkda123122.htm 0001172661-23-001160 005-88855 23626328 34 90526
2023-02-02 4 FORM 4 SUBMISSION 0001209191-23-006429 5449
2023-01-20 SC 13D/A SC 13D/A 0001193125-23-012167 005-88855 23542008 34 126368
2023-01-06 DEF 14A DEF 14A 0000950170-23-000333 001-37383 23515179 34 1543879
2023-01-05 4 FORM 4 SUBMISSION 0001209191-23-002182 5571
2023-01-05 3 FORM 3 SUBMISSION 0001209191-23-002168 15435
2023-01-05 8-K/A 8-K/A 5.02,9.01 0000950170-23-000232 001-37383 23511445 34 642090 1 1
2022-12-23 PRE 14A PRE 14A 0000950170-22-027008 001-37383 221485511 34 1552975
2022-12-08 8-K 8-K 3.03,5.03,9.01 0000950170-22-026239 001-37383 221452785 34 221334 1 1
2022-12-08 8-A12G 8-A12G 0000950170-22-026235 000-56500 221452520 34 108550
2022-11-30 8-K 8-K 5.02,7.01,9.01 0000950170-22-025876 001-37383 221435984 34 321523 1 1
2022-11-10 10-Q 10-Q 0000950170-22-024557 001-37383 221378181 34 15060415 1 1
2022-11-10 8-K 8-K 2.02,9.01 0000950170-22-024462 001-37383 221377255 34 962131 1 1
2022-10-07 424B3 424B3 0000950170-22-019397 333-267637 221301400 33 227606
2022-10-05 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2022-10-05 16:00:00 9999999995-22-002945 333-267637 221297027 33 1711
2022-10-04 CORRESP filename1.htm 0000950170-22-019271 15197
2022-10-03 UPLOAD filename1.pdf 0000000000-22-010862 40191
2022-09-27 S-1 S-1 0001564590-22-032479 333-267637 221272103 33 689949
2022-09-27 8-K 8-K 3.01 0000950170-22-018903 001-37383 221271644 34 170064 1 1
2022-08-18 4 FORM 4 SUBMISSION 0001209191-22-046793 5315
2022-08-18 4 FORM 4 SUBMISSION 0001209191-22-046792 5315
2022-08-16 8-K 8-K 1.01,3.02,9.01 0000950170-22-017516 001-37383 221170885 34 1431380 1 1
2022-08-16 424B5 424B5 0000950170-22-017484 333-264425 221168771 33 458897
2022-08-11 10-Q 10-Q 0000950170-22-016942 001-37383 221156872 34 12961371 1 1
2022-08-11 8-K 8-K 2.02,9.01 0000950170-22-016854 001-37383 221155729 34 890377 1 1
2022-08-03 4 FORM 4 SUBMISSION 0001209191-22-044269 5427
2022-06-07 8-K 8-K 5.02,5.07 0000950170-22-011278 001-37383 221001668 34 199612 1 1
2022-06-03 4 FORM 4 SUBMISSION 0001209191-22-034139 5409
2022-06-03 4 FORM 4 SUBMISSION 0001209191-22-034126 5394
2022-06-03 4 FORM 4 SUBMISSION 0001209191-22-034108 5384
2022-06-03 4 FORM 4 SUBMISSION 0001209191-22-033912 5362
2022-06-03 4 FORM 4 SUBMISSION 0001209191-22-033874 5388
2022-06-03 4 FORM 4 SUBMISSION 0001209191-22-033860 5373
2022-05-31 S-8 S-8 0001564590-22-021903 333-265322 22984184 33 164755
2022-05-12 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-05-12 16:00:00 9999999995-22-001440 333-264425 22920057 33 1710
2022-05-12 10-Q 10-Q 0000950170-22-009747 001-37383 22918768 34 11686790 1 1
2022-05-12 8-K 8-K 2.02,9.01 0000950170-22-009652 001-37383 22917800 34 685176 1 1
2022-05-10 CORRESP filename1.htm 0000950170-22-008976 13631
2022-04-27 UPLOAD filename1.pdf 0000000000-22-004518 40172
2022-04-21 S-3 S-3 SHELF 2022 0001564590-22-015103 333-264425 22842369 33 595101
2022-04-19 DEFA14A DEFA14A 0000950170-22-005804 001-37383 22834475 34 255193
2022-04-19 DEF 14A DEF 14A 0000950170-22-005802 001-37383 22834394 34 1567253
2022-04-13 4 FORM 4 SUBMISSION 0001209191-22-024268 7791
2022-04-13 4 FORM 4 SUBMISSION 0001209191-22-024267 11727
2022-03-31 10-K 10-K 0000950170-22-005253 001-37383 22794616 34 20002569 1 1
2022-03-30 8-K 8-K 2.02,9.01 0000950170-22-005046 001-37383 22786542 34 871675 1 1
2022-02-11 424B3 424B3 0000950170-22-001137 333-262407 22622898 33 835693
2022-02-11 SC 13G/A AMENDMENT NO. 4 TO SCHEDULE 13G 0001213900-22-006717 005-88855 22616817 34 53813
2022-02-09 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2022-02-09 16:00:00 9999999995-22-000379 333-262407 22609369 33 1710
2022-02-07 8-K 8-K 5.02,9.01 0000950170-22-000832 001-37383 22597706 34 639327 1 1
2022-02-04 SC 13G/A RKDA 13G/A 0001393825-22-000095 005-88855 22593074 34 55528
2022-02-04 4 FORM 4 SUBMISSION 0001209191-22-007154 5425
2022-02-04 3 FORM 3 SUBMISSION 0001209191-22-007152 6877
2022-02-03 CORRESP filename1.htm 0000950170-22-000728 12973
2022-02-02 UPLOAD filename1.pdf 0000000000-22-001317 40178
2022-01-28 S-1 S-1_RESALE-2020-WARRANTS 0001564590-22-003046 333-262407 22569707 33 1161253
2021-12-20 8-K 8-K 5.02,9.01 0000950170-21-005288 001-37383 211505954 34 351538 1 1
2021-11-19 8-K 8-K 5.02 0000950170-21-004812 001-37383 211428714 34 163995 1 1
2021-11-15 10-Q 10-Q 0000950170-21-004634 001-37383 211411927 34 14588226 1 1
2021-11-15 8-K 8-K 2.02,9.01 0000950170-21-004590 001-37383 211410514 34 910921 1 1
2021-10-12 8-K/A 8-K/A 5.07 0001564590-21-050615 001-37383 211318221 34 167798 1 1
2021-09-07 8-K 8-K 5.02,9.01 0000950170-21-001688 001-37383 211239829 34 677188 1 1
2021-08-16 10-Q 10-Q 0001564590-21-044701 001-37383 211179607 34 13564405 1 1
2021-08-16 8-K 8-K 2.02,9.01 0001564590-21-044632 001-37383 211178231 34 748825
2021-08-02 8-K/A 8-K/A 9.01 0001564590-21-039808 001-37383 211136758 34 1930897
2021-07-20 8-K 8-K 5.02 0001564590-21-037217 001-37383 211101055 34 33180
2021-07-13 4 FORM 4 SUBMISSION 0001209191-21-046592 5418
2021-07-13 3 FORM 3 SUBMISSION 0001209191-21-046591 6883
2021-07-06 8-K 8-K 2.01 0001564590-21-035859 001-37383 211074056 34 27001
2021-07-02 8-K 8-K 5.07 0001564590-21-035716 001-37383 211069682 34 53276
2021-06-16 DEFA14A DEFA14A 0001564590-21-033223 001-37383 211022203 34 52527
2021-06-07 DEFA14A DEFA14A 0001564590-21-031981 001-37383 211000446 34 25702
2021-06-07 8-K 8-K 8.01 0001564590-21-031978 001-37383 211000364 34 29496
2021-06-04 4 FORM 4 SUBMISSION 0001209191-21-038217 5389
2021-06-04 4 FORM 4 SUBMISSION 0001209191-21-038203 5385
2021-06-04 4 FORM 4 SUBMISSION 0001209191-21-038196 5374
2021-06-04 4 FORM 4 SUBMISSION 0001209191-21-038190 5409
2021-06-04 4 FORM 4 SUBMISSION 0001209191-21-038167 5363
2021-06-04 4 FORM 4 SUBMISSION 0001209191-21-038166 5395
2021-05-28 S-8 S-8 0001564590-21-030776 333-256599 21979932 33 214959
2021-05-21 8-K 8-K 1.01,2.01,3.02,5.02,9.01 0001564590-21-029293 001-37383 21948882 34 592153
2021-05-20 4 FORM 4 SUBMISSION 0001209191-21-034432 5423
2021-05-20 3 FORM 3 SUBMISSION 0001209191-21-034431 6892
2021-05-17 10-Q 10-Q 0001564590-21-028456 001-37383 21932088 34 10472227 1
2021-05-17 8-K 8-K 2.02,9.01 0001564590-21-028386 001-37383 21930639 34 262670
2021-04-20 DEFA14A DEFA14A 0001564590-21-019598 001-37383 21837553 34 282661
2021-04-20 DEF 14A DEF 14A 0001564590-21-019590 001-37383 21837515 34 1306408
2021-04-02 SEC STAFF LETTER filename1.pdf 9999999997-21-001104 274499
2021-03-31 10-K 10-K 0001564590-21-017118 001-37383 21794316 34 14539412 1
2021-03-30 8-K 8-K 2.02,9.01 0001564590-21-016672 001-37383 21786838 34 265100
2021-03-05 SEC STAFF LETTER filename1.pdf 9999999997-21-000896 276225
2021-02-24 4 FORM 4 SUBMISSION 0001209191-21-013784 5483
2021-02-24 3 FORM 3 SUBMISSION 0001209191-21-013750 6841
2021-02-24 8-K 8-K 5.02,9.01 0001564590-21-008050 001-37383 21672792 34 63210
2021-02-16 D xslFormDX01/primary_doc.xml 06b 0001469443-21-000001 021-389434 21630064 33 11998
2021-02-12 424B3 424B3 0001564590-21-005641 333-252659 21622482 33 493222
2021-02-11 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-02-11 17:00:00 9999999995-21-000613 333-252659 21622454 33 1711
2021-02-10 SC 13G/A RKDA 13GA 0001393825-21-000062 005-88855 21613655 34 55015
2021-02-09 CORRESP filename1.htm 0001564590-21-005036 8756
2021-02-05 UPLOAD filename1.pdf 0000000000-21-001533 40211
2021-02-02 S-3 S-3 2021 PIPE 0001564590-21-003752 333-252659 21579907 33 683242
2021-01-29 8-K 8-K 1Q 2021 SPA 1.01,3.02,9.01 0001564590-21-003281 001-37383 21569497 34 762182
2021-01-29 SC 13G/A AMENDMENT NO. 3 TO SCHEDULE 13G 0001213900-21-005165 005-88855 21568074 34 79987
2021-01-25 4 FORM 4 SUBMISSION 0001209191-21-005219 7264
2021-01-25 4 FORM 4 SUBMISSION 0001209191-21-005218 7190
2021-01-25 4 FORM 4 SUBMISSION 0001209191-21-005213 11179
2020-12-22 8-K 8-K 4Q 2020 RDO 1.01,3.02,9.01 0001564590-20-057965 001-37383 201406979 34 1151203
2020-12-22 424B5 424B5 0001564590-20-057962 333-224893 201406918 33 410153
2020-11-18 8-K 8-K 1.01,2.01,9.01 0001564590-20-054479 001-37383 201324790 34 46009
2020-11-13 10-Q 10-Q 0001564590-20-053848 001-37383 201310903 34 10050999 1
2020-11-12 8-K 8-K 2.02,9.01 0001564590-20-053313 001-37383 201303447 34 753118
2020-09-11 424B3 424B3 0001564590-20-043284 333-239641 201171569 33 194277
2020-09-03 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2020-09-03 16:00:00 9999999995-20-002352 333-239641 201160536 33 1712
2020-09-01 CORRESP filename1.htm 0001564590-20-042203 8864
2020-08-13 10-Q 10-Q 0001564590-20-040076 001-37383 201100287 34 9226270 1
2020-08-13 S-3/A S-3/A 0001564590-20-040071 333-239641 201100199 33 392367
2020-08-13 8-K 8-K 2.02,9.01 0001564590-20-040025 001-37383 201099457 34 754045
2020-07-22 S-3/A S-3/A 0001564590-20-033085 333-239641 201042068 33 160847
2020-07-10 4 FORM 4 SUBMISSION 0001209191-20-042125 5300
2020-07-10 4 FORM 4 SUBMISSION 0001209191-20-042124 5275
2020-07-08 UPLOAD filename1.pdf 0000000000-20-006130 40225
2020-07-08 8-K 8-K 1.01,3.02,9.01 0001564590-20-032052 001-37383 201018838 34 383997
2020-07-06 8-K 8-K 1.01,3.02 0001564590-20-031777 001-37383 201012329 34 30338
2020-07-02 S-3 S-3 0001564590-20-031637 333-239641 201008522 33 388127
2020-07-02 8-K 8-K 1.01,2.03,9.01 0001564590-20-031636 001-37383 201008504 34 362801
2020-06-03 8-K 8-K 5.07 0001564590-20-028230 001-37383 20940274 34 39275
2020-06-03 4 FORM 4 SUBMISSION 0001209191-20-033828 9522
2020-06-03 4 FORM 4 SUBMISSION 0001209191-20-033827 9553
2020-06-03 4 FORM 4 SUBMISSION 0001209191-20-033826 9469
2020-06-03 4 FORM 4 SUBMISSION 0001209191-20-033825 13866
2020-06-03 4 FORM 4 SUBMISSION 0001209191-20-033824 13464
2020-05-18 8-K 8-K 1.01,3.02,9.01 0001564590-20-025981 001-37383 20889224 34 366916
2020-05-18 424B3 424B3 0001564590-20-025980 333-229047 20889221 33 9533
2020-05-14 8-K 8-K 1.01,3.02 0001564590-20-025284 001-37383 20875477 34 30256
2020-05-13 10-Q 10-Q 0001564590-20-025131 001-37383 20874196 34 6891425 1
2020-05-13 8-K 8-K 2.02,9.01 0001564590-20-025057 001-37383 20873259 34 578524
2020-04-21 8-K 8-K 1.01,2.03,9.01 0001564590-20-017687 001-37383 20805220 34 92668
2020-04-17 DEFA14A DEFA14A 0001564590-20-017267 001-37383 20799887 34 206795
2020-04-17 DEF 14A DEF 14A 0001564590-20-017258 001-37383 20799814 34 1189946
2020-04-03 4 FORM 4 SUBMISSION 0001209191-20-023345 9316
2020-04-03 3 FORM 3 SUBMISSION 0001209191-20-023342 10105
2020-03-27 S-8 S-8 0001564590-20-013572 333-237438 20751500 33 114767
2020-03-25 10-K 10-K 0001564590-20-012875 001-37383 20743233 34 13176940 1
2020-03-25 8-K 8-K 2.02,9.01 0001564590-20-012822 001-37383 20742280 34 659011
2020-02-14 SC 13G/A SC 13G/A 0001193125-20-038344 005-88855 20620579 34 123571
2020-02-14 SC 13G/A SC 13G/A 0001104659-20-021843 005-88855 20620533 34 79956
2020-02-11 SC 13G/A AMENDMENT NO. 2 TO SCHEDULE 13G 0001213900-20-003214 005-88855 20593804 34 79650
2020-02-04 4 FORM 4 SUBMISSION 0001209191-20-006294 11100
2020-02-04 4 FORM 4 SUBMISSION 0001209191-20-006290 7131
2020-02-04 4 FORM 4 SUBMISSION 0001209191-20-006282 7185
2020-01-23 424B3 424B3 0001564590-20-001677 333-232858 20539770 33 26151
2019-12-23 4 FORM 4 SUBMISSION 0001209191-19-061814 4495
2019-12-20 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2019-12-20 16:00:00 9999999995-19-002893 333-235446 191303362 33 1703
2019-12-18 CORRESP filename1.htm 0001564590-19-046289 8750
2019-12-17 UPLOAD filename1.pdf 0000000000-19-016499 45989
2019-12-11 S-1 S-1 0001193125-19-310417 333-235446 191278629 33 217538
2019-11-20 4 FORM 4 SUBMISSION 0001209191-19-057375 4496
2019-11-19 4 FORM 4 SUBMISSION 0001209191-19-057084 4473
2019-11-18 4 FORM 4 SUBMISSION 0001209191-19-056884 4559
2019-11-06 10-Q 10-Q 0001564590-19-041132 001-37383 191197250 34 8197908 1
2019-11-06 8-K 8-K 2.02,9.01 0001564590-19-041018 001-37383 191196408 34 700466
2019-10-07 8-K/A 8-K/A 5.02,9.01 0001564590-19-036506 001-37383 191139336 34 308219
2019-10-04 8-K 8-K 5.02 0001564590-19-036411 001-37383 191136905 34 27881
2019-09-23 4 FORM 4 SUBMISSION 0001209191-19-050493 4558
2019-09-17 4 FORM 4 SUBMISSION 0001209191-19-049954 4506
2019-09-16 SC 13G d8368939_13g.htm 0000919574-19-005894 005-88855 191095436 34 114211
2019-09-13 8-K 8-K 5.02,8.01 0001564590-19-034733 001-37383 191093188 34 27440
2019-09-11 SC 13G SC 13G 0001193125-19-242789 005-88855 191087972 34 127361
2019-09-10 4 FORM 4 SUBMISSION 0001209191-19-049077 6088
2019-09-10 3 FORM 3 SUBMISSION 0001209191-19-049071 19060
2019-09-10 4 FORM 4 SUBMISSION 0001209191-19-049070 4501
2019-09-10 4 FORM 4 SUBMISSION 0001209191-19-049067 6029
2019-09-09 8-K 8-K 1.01,3.02,9.01 0001564590-19-034379 001-37383 191083716 34 771326
2019-09-09 424B5 424B5 0001193125-19-241094 333-224893 191083695 33 288714
2019-09-09 SC 13G SCHEDULE 13G 0001144204-19-043927 005-88855 191083116 34 78619
2019-08-28 8-K 8-K 5.02,9.01 0001564590-19-033353 001-37383 191062422 34 139312
2019-08-28 4/A FORM 4/A SUBMISSION 0001209191-19-047582 13877
2019-08-28 4 FORM 4 SUBMISSION 0001209191-19-047580 13691
2019-08-28 424B3 424B3 0001193125-19-231252 333-232858 191059075 33 96377
2019-08-27 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2019-08-27 16:00:00 9999999995-19-001969 333-232858 191059064 33 1703
2019-08-26 CORRESP filename1.htm 0001193125-19-229360 8113
2019-08-21 CORRESP filename1.htm 0001193125-19-225559 27828
2019-08-21 S-1/A S-1/A 0001193125-19-225557 333-232858 191041194 33 209189
2019-08-14 10-Q 10-Q 0001564590-19-032192 001-37383 191027686 34 7011006 1
2019-08-14 8-K 8-K 2.02,9.01 0001564590-19-032099 001-37383 191025578 34 631466
2019-08-09 8-K 8-K 1.01,9.01 0001564590-19-031308 001-37383 191013924 34 414638
2019-08-06 UPLOAD filename1.pdf 0000000000-19-012130 44565
2019-07-26 S-1 S-1 0001193125-19-204064 333-232858 19978442 33 550487
2019-06-14 8-K 8-K 1.01,3.02,9.01 0001564590-19-022531 001-37383 19897898 34 745018
2019-06-14 424B5 424B5 0001193125-19-173160 333-224893 19897801 33 287246
2019-06-11 S-8 S-8 0001564590-19-022276 333-232072 19891861 33 457774
2019-06-07 8-K 8-K 5.07,9.01 0001564590-19-022034 001-37383 19885983 34 376145
2019-06-07 4 FORM 4 SUBMISSION 0001209191-19-035510 9551
2019-06-07 4 FORM 4 SUBMISSION 0001209191-19-035500 9621
2019-06-07 4 FORM 4 SUBMISSION 0001209191-19-035492 9728
2019-06-04 4 FORM 4 SUBMISSION 0001209191-19-034598 9428
2019-06-04 4 FORM 4 SUBMISSION 0001209191-19-034596 9471
2019-06-04 4 FORM 4 SUBMISSION 0001209191-19-034585 9466
2019-06-04 4 FORM 4 SUBMISSION 0001209191-19-034583 9437
2019-06-04 4 FORM 4 SUBMISSION 0001209191-19-034580 9457
2019-06-04 4 FORM 4 SUBMISSION 0001209191-19-034578 9438
2019-05-24 8-K 8-K 3.01 0001564590-19-020473 001-37383 19854658 34 27213
2019-05-08 10-Q 10-Q 0001564590-19-017310 001-37383 19807537 34 6067258 1
2019-05-08 8-K 8-K 2.02,9.01 0001564590-19-017218 001-37383 19806802 34 484006
2019-04-30 DEFA14A DEFA14A 0001564590-19-013838 001-37383 19777709 34 194827
2019-04-18 DEF 14A DEF 14A 0001564590-19-012009 001-37383 19756466 34 1478804
2019-04-01 10-K 10-K 0001564590-19-010452 001-37383 19721722 34 10404092 1
2019-03-27 8-K 8-K 2.02,9.01 0001564590-19-009586 001-37383 19708570 34 571916
2019-02-28 8-K 8-K 8.01,9.01 0001564590-19-005220 001-37383 19640715 34 73526
2019-02-14 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2019-02-14 17:00:00 9999999995-19-000267 333-229047 19609738 33 1702
2019-02-14 SC 13G/A SC 13G/A 0001104659-19-008592 005-88855 19604189 34 87119
2019-02-13 CORRESP filename1.htm 0001193125-19-038119 7034
2019-02-13 8-K 8-K 8.01 0001564590-19-002838 001-37383 19597723 34 495876
2019-02-08 SC 13G/A AMENDMENT NO. 1 TO SCHEDULE 13G 0001213900-19-001901 005-88855 19579095 34 66594
2019-02-08 UPLOAD filename1.pdf 0000000000-19-001509 45969
2019-02-05 SC 13G RKDA 13G 0001393825-19-000090 005-88855 19567149 34 63291
2019-01-04 SC 13G/A SABBY 13G-A RKDA 1.04.19 0001535610-19-000022 005-88855 19508848 34 13225
2018-12-27 S-1 S-1 0001193125-18-359270 333-229047 181255147 33 2201420
2018-11-07 10-Q 10-Q 0001564590-18-028112 001-37383 181167285 34 6192100 1
2018-11-07 8-K 8-K 2.02,9.01 0001564590-18-028025 001-37383 181166451 34 825646
2018-09-20 4 FORM 4 SUBMISSION 0001209191-18-051841 5382
2018-09-20 4 FORM 4 SUBMISSION 0001209191-18-051840 9436
2018-09-20 4 FORM 4 SUBMISSION 0001209191-18-051839 5554
2018-08-08 10-Q 10-Q 0001564590-18-020562 001-37383 181002293 34 6357255 1
2018-08-08 8-K 8-K 2.02,9.01 0001564590-18-020491 001-37383 181001542 34 855256
2018-08-03 8-K 8-K 5.02 0001564590-18-019212 001-37383 18992955 34 24292
2018-06-21 SC 13G SCHEDULE 13G 0001213900-18-008022 005-88855 18912147 34 89935
2018-06-21 SC 13G SC 13G 0001104659-18-041510 005-88855 18911474 34 103546
2018-06-14 8-K 8-K 1.01,3.02,9.01 0001564590-18-015580 001-37383 18897795 34 771897
2018-06-13 424B5 424B5 0001193125-18-191772 333-224893 18897520 33 291612
2018-06-11 8-K 8-K ANNUAL MEETING 5.07 0001564590-18-015415 001-37383 18892641 34 39831
2018-06-08 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2018-06-08 17:00:00 9999999995-18-001458 333-224893 18890851 33 1702
2018-06-08 4 FORM 4 SUBMISSION 0001209191-18-036806 5280
2018-06-08 4 FORM 4 SUBMISSION 0001209191-18-036805 5352
2018-06-08 4 FORM 4 SUBMISSION 0001209191-18-036801 5399
2018-06-08 4 FORM 4 SUBMISSION 0001209191-18-036795 5380
2018-06-08 4 FORM 4 SUBMISSION 0001209191-18-036792 5379
2018-06-08 4 FORM 4 SUBMISSION 0001209191-18-036791 5385
2018-06-08 3 FORM 3 SUBMISSION 0001209191-18-036757 7672
2018-06-06 CORRESP filename1.htm 0001193125-18-185676 17415
2018-05-29 CORRESP filename1.htm 0001193125-18-176901 45132
2018-05-24 UPLOAD filename1.pdf 0000000000-18-016126 46483
2018-05-17 8-K 8-K 8.01 0001564590-18-013884 001-37383 18843827 34 25815
2018-05-17 DEF 14A DEF 14A 0001564590-18-013881 001-37383 18843663 34 1082380
2018-05-16 8-K 8-K 5.02,9.01 0001564590-18-013783 001-37383 18840665 34 48670
2018-05-15 4 FORM 4 SUBMISSION 0001209191-18-030360 5533
2018-05-15 3 FORM 3 SUBMISSION 0001209191-18-030349 7333
2018-05-11 S-3 S-3 0001193125-18-161053 333-224893 18827945 33 288400
2018-05-09 10-Q 10-Q 0001564590-18-012544 001-37383 18819623 34 5194837 1
2018-05-09 8-K 8-K 2.02,9.01 0001564590-18-012439 001-37383 18818652 34 687710
2018-05-08 8-K 8-K 5.07 0001564590-18-011420 001-37383 18812793 34 28590
2018-04-24 424B3 424B3 0001193125-18-127562 333-224061 18770000 33 75872
2018-04-23 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2018-04-23 16:00:00 9999999995-18-000888 333-224061 18769976 33 1702

Latest XBRL company facts

One latest value per concept from companyfacts (439 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 6.07M 2026-11-05 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
dei EntityListingParValuePerShare Entity Listing, Par Value Per Share USD/shares 0.001 2025-01-01 2025-12-31 2025 FY 10-K/A 2026-04-30 0001193125-26-197315
dei EntityPublicFloat Entity Public Float USD 5.74M 2025-06-30 2025 FY 10-K/A 2026-04-30 0001193125-26-197315
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 111,907 2025-01-01 2025-12-31 DEF 14A 2026-08-10 0001193125-26-342437
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 218,425 2025-01-01 2025-12-31 DEF 14A 2026-08-10 0001193125-26-342437
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 36 2025-01-01 2025-12-31 DEF 14A 2026-08-10 0001193125-26-342437
ffd NetFeeAmt NetFeeAmt USD 15.47 2026-09-30 S-8 2026-09-30 0001193125-26-409063
ffd TtlFeeAmt TtlFeeAmt USD 15.47 2026-09-30 S-8 2026-09-30 0001193125-26-409063
ffd TtlOfferingAmt TtlOfferingAmt USD 112,000 2026-09-30 S-8 2026-09-30 0001193125-26-409063
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-09-30 S-8 2026-09-30 0001193125-26-409063
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-06-24 S-3 2026-06-26 0001193125-26-285578
us-gaap AccountsAndOtherReceivablesNetCurrent Accounts and Other Receivables, Net, Current USD 625,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 1.01M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap AccountsPayableTradeCurrent Accounts Payable, Trade, Current USD 1.45M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 3.85M 2022-06-30 2022 Q2 10-Q 2022-08-11 0000950170-22-016942
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 44,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-31 0000950170-22-005253
us-gaap AccruedPayrollTaxesCurrent Accrued Payroll Taxes, Current USD 0 2018-12-31 2018 FY 10-K 2019-04-01 0001564590-19-010452
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 50,000 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap AccruedRoyaltiesCurrent Accrued Royalties, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 1.91M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 0 2024-12-31 2024 FY 10-K 2025-03-25 0000950170-25-044487
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 27.90M 2015-03-31 2015 Q1 10-Q 2015-06-25 0001193125-15-233674
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 292.45M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 14,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 888,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012544
us-gaap AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation USD 1.00M 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-08 0001564590-16-014230
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 526,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-25 0001564590-20-012875
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 234,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 559,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 98,000 2017-01-01 2017-12-31 2018 FY 10-K 2019-04-01 0001564590-19-010452
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038176
us-gaap AmortizationOfLeasedAsset Amortization of Leased Asset USD 914,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0000950170-21-004634
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 10.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 160,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011019
us-gaap Assets Assets USD 4.72M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap AssetsCurrent Assets, Current USD 4.56M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap AssetsHeldForSaleLongLivedFairValueDisclosure Assets Held-for-sale, Long Lived, Fair Value Disclosure USD 51,000 2023-12-31 2024 FY 10-K 2025-03-25 0000950170-25-044487
us-gaap AssetsHeldForSaleNotPartOfDisposalGroup Assets Held-for-sale, Not Part of Disposal Group USD 0 2021-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011019
us-gaap AssetsHeldForSaleNotPartOfDisposalGroupCurrent Assets Held-for-sale, Not Part of Disposal Group, Current USD 0 2024-12-31 2024 FY 10-K 2025-03-25 0000950170-25-044487
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperation Disposal Group, Including Discontinued Operation, Assets USD 0 2024-03-31 2024 Q1 10-Q 2024-05-13 0000950170-24-058563
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Assets, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2020-09-30 2020 Q3 10-Q 2020-11-13 0001564590-20-053848
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 0 2020-09-30 2020 Q3 10-Q 2020-11-13 0001564590-20-053848
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 8.06M 2020-09-30 2020 Q3 10-Q 2020-11-13 0001564590-20-053848
us-gaap AvailableForSaleSecurities Available-for-sale Securities USD 24.26M 2018-09-30 2018 Q3 10-Q 2018-11-07 0001564590-18-028112
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax USD 0 2018-09-30 2018 Q3 10-Q 2018-11-07 0001564590-18-028112
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax USD 2,000 2018-09-30 2018 Q3 10-Q 2018-11-07 0001564590-18-028112
us-gaap AvailableForSaleSecuritiesAmortizedCost Available-for-sale Securities, Amortized Cost Basis USD 24.26M 2018-09-30 2018 Q3 10-Q 2018-11-07 0001564590-18-028112
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss USD 0 2017-12-31 2017 FY 10-K 2018-03-20 0001564590-18-006338
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 8.06M 2020-09-30 2020 Q3 10-Q 2020-11-13 0001564590-20-053848
us-gaap BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 58,000 2021-01-01 2021-06-30 2022 Q2 10-Q 2022-08-11 0000950170-22-016942
us-gaap Cash Cash USD 20.40M 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012544
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 2.84M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 2.65M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-14 0001564590-19-032192
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 2.84M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 2.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 6.31 2020-09-30 2020 Q3 10-Q 2020-11-13 0001564590-20-053848
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 982,080 2018-05-31 2018 Q2 10-Q 2018-08-08 0001564590-18-020562
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 936,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap CommonStockNoParValue Common Stock, No Par Value USD/shares 0 2015-03-31 2015 Q1 10-Q 2015-06-25 0001193125-15-233674
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 150.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 5.13M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 5.13M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap CommonStockValue Common Stock, Value, Issued USD 67,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -2.34M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap ContractsRevenue Contracts Revenue (Deprecated 2018-01-31) USD 153,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012544
us-gaap ContractualObligation Contractual Obligation USD 1.25M 2020-09-30 2020 Q3 10-Q 2020-11-13 0001564590-20-053848
us-gaap ContractualObligationDueInNextTwelveMonths Contractual Obligation, to be Paid, Year One USD 750,000 2020-09-30 2020 Q3 10-Q 2020-11-13 0001564590-20-053848
us-gaap ContractualObligationDueInSecondYear Contractual Obligation, to be Paid, Year Two USD 750,000 2020-03-31 2020 Q1 10-Q 2020-05-13 0001564590-20-025131
us-gaap ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear Contractual Obligation, to be Paid, Remainder of Fiscal Year USD 500,000 2020-09-30 2020 Q3 10-Q 2020-11-13 0001564590-20-053848
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 8,000 2020-12-31 2021 FY 10-K 2022-03-31 0000950170-22-005253
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 2.04M 2017-12-31 2018 FY 10-K 2019-04-01 0001564590-19-010452
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 96,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-25 0001564590-20-012875
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 2,000 2017-01-01 2017-12-31 2018 FY 10-K 2019-04-01 0001564590-19-010452
us-gaap ConvertibleLongTermNotesPayable Convertible Notes Payable, Noncurrent USD 4.50M 2013-12-31 2015 Q3 10-Q 2015-11-05 0001564590-15-009725
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 0 2015-12-31 2015 FY 10-K 2016-03-08 0001564590-16-014230
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 32.97M 2015-05-31 2016 FY 10-K 2017-03-08 0001564590-17-003724
us-gaap CostMethodInvestments Cost Method Investments USD 0 2015-12-31 2017 FY 10-K 2018-03-20 0001564590-18-006338
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 2.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap CostOfGoodsSold Cost of Goods Sold (Deprecated 2018-01-31) USD 36,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012544
us-gaap CostsAndExpenses Costs and Expenses USD 6.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 8,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 8,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap DebtAndEquitySecuritiesRealizedGainLoss Debt and Equity Securities, Realized Gain (Loss) USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011019
us-gaap DebtAndEquitySecuritiesUnrealizedGainLoss Debt and Equity Securities, Unrealized Gain (Loss) USD 7.46M 2021-01-01 2021-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009747
us-gaap DebtCurrent Debt, Current USD 0 2021-12-31 2021 FY 10-K 2022-03-31 0000950170-22-005253
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.076 2020-03-31 2020 Q1 10-Q 2020-05-13 0001564590-20-025131
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 46,000 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-08 0001564590-18-020562
us-gaap DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain (Loss), before Tax USD 0 2019-09-30 2019 Q3 10-Q 2019-11-06 0001564590-19-041132
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss USD 0 2025-03-31 2025 Q1 10-Q 2025-05-08 0000950170-25-066425
us-gaap DebtSecuritiesUnrealizedGainLoss Debt Securities, Unrealized Gain (Loss) USD -4.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap DeferredIncomeTaxesAndTaxCredits Deferred Income Taxes and Tax Credits USD -107,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-31 0000950170-22-005253
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 0 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 226,000 2019-12-31 2019 FY 10-K 2020-03-25 0001564590-20-012875
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 316,000 2018-09-30 2018 Q3 10-Q 2018-11-07 0001564590-18-028112
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 2.04M 2017-12-31 2018 Q3 10-Q 2018-11-07 0001564590-18-028112
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap DeferredTaxAssetsCapitalLossCarryforwards Deferred Tax Assets, Capital Loss Carryforwards USD 0 2017-12-31 2017 FY 10-K 2018-03-20 0001564590-18-006338
us-gaap DeferredTaxAssetsCharitableContributionCarryforwards Deferred Tax Assets, Charitable Contribution Carryforwards USD 0 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 0 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011019
us-gaap DeferredTaxAssetsDerivativeInstruments Deferred Tax Assets, Derivative Instruments USD 0 2015-12-31 2015 FY 10-K 2016-03-08 0001564590-16-014230
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 309,000 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap DeferredTaxAssetsInventory Deferred Tax Assets, Inventory USD 0 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 30.48M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 27.29M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 102,000 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 16,000 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 572,000 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts USD 1.29M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 30.48M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap DeferredTaxExpenseFromStockOptionsExercised Deferred Tax Expense from Stock Options Exercised USD 2.70M 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-08 0001564590-16-014230
us-gaap DeferredTaxLiabilitiesFinancingArrangements Deferred Tax Liabilities, Financing Arrangements USD 0 2015-12-31 2015 FY 10-K 2016-03-08 0001564590-16-014230
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets Deferred Tax Liabilities, Intangible Assets USD 0 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011019
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 0 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011019
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 0.5 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent pure 0.03 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap Depreciation Depreciation USD 8,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 133,000 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-06 0001564590-19-041132
us-gaap DerivativeLiabilities Derivative Liability USD 15.90M 2018-03-31 2019 Q3 10-Q 2019-11-06 0001564590-19-041132
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 0 2015-12-31 2015 FY 10-K 2016-03-08 0001564590-16-014230
us-gaap DerivativeLossOnDerivative Derivative, Loss on Derivative USD 4.00M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-25 0001564590-20-012875
us-gaap DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent Disposal Group, Including Discontinued Operation, Assets, Noncurrent USD 0 2024-12-31 2024 FY 10-K 2025-03-25 0000950170-25-044487
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 15,000 2023-03-31 2023 Q1 10-Q 2023-05-15 0000950170-23-022199
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -2.39 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.69 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-31 0000950170-22-005253
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -2.39 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.758 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-04-01 0001564590-19-010452
us-gaap EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Percent pure 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038176
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-04-01 0001564590-19-010452
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0.003 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.01 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-25 0000950170-25-044487
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount USD 319,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure -0.136 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.003 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD -1,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0000950170-21-004634
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011019
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 107,000 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 91,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap EquityMethodInvestmentRealizedGainLossOnDisposal Equity Method Investment, Realized Gain (Loss) on Disposal USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038176
us-gaap EquitySecuritiesFvNiGainLoss Equity Securities, FV-NI, Gain (Loss) USD -2.88M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001193125-26-223990
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 176,000 2021-01-01 2021-06-30 2022 Q2 10-Q 2022-08-11 0000950170-22-016942
us-gaap FairValueAssumptionsExpectedVolatilityRate Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) pure 1 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012544
us-gaap FairValueAssumptionsRiskFreeInterestRate Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) pure 0.026 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012544
us-gaap FairValueHedgesAtFairValueNet Fair Value Hedges, Net USD 500,000 2015-12-31 2017 FY 10-K 2018-03-20 0001564590-18-006338
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Period Increase (Decrease) USD 845,000 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-05 0001564590-15-009725
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs USD 2.42M 2015-09-30 2015 Q3 10-Q 2015-11-05 0001564590-15-009725
us-gaap FairValueOptionChangesInFairValueGainLoss1 Fair Value, Option, Changes in Fair Value, Gain (Loss) USD -1.90M 2018-01-01 2018-03-31 2019 Q3 10-Q 2019-11-06 0001564590-19-041132
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 172,000 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011019
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 28,000 2021-12-31 2021 FY 10-K 2022-03-31 0000950170-22-005253
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 53,000 2022-09-30 2022 Q3 10-Q 2022-11-10 0000950170-22-024557
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 13,000 2022-09-30 2022 Q3 10-Q 2022-11-10 0000950170-22-024557
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 4,000 2021-12-31 2021 FY 10-K 2022-03-31 0000950170-22-005253
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 4,000 2022-09-30 2022 Q3 10-Q 2022-11-10 0000950170-22-024557
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 4,000 2022-09-30 2022 Q3 10-Q 2022-11-10 0000950170-22-024557
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 53,000 2022-09-30 2022 Q3 10-Q 2022-11-10 0000950170-22-024557
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 177,000 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011019
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 5,000 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011019
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD -497,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011019
us-gaap GainLossOnDispositionOfIntangibleAssets Gain (Loss) on Disposition of Intangible Assets USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap GainLossOnInvestments Gain (Loss) on Investments USD 1.07M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0000950170-25-109040
us-gaap GainLossOnSaleOfAccountsReceivable Gain (Loss) on Sale of Accounts Receivable USD -4.75M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap GainLossOnSaleOfBusiness Gain (Loss) on Disposition of Business USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011019
us-gaap GainLossOnSaleOfInvestments Gain (Loss) on Sale of Investments USD -2,000 2017-01-01 2017-12-31 2018 FY 10-K 2019-04-01 0001564590-19-010452
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 0 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-08 0000950170-25-066425
us-gaap GainOnSaleOfInvestments Gain on Sale of Investments USD 10.20M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011019
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD -635,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-31 0000950170-22-005253
us-gaap Goodwill Goodwill USD 408,000 2020-12-31 2021 FY 10-K 2022-03-31 0000950170-22-005253
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011019
us-gaap ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038176
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 530,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038176
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -2.33M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -2.33M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -17.93M 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-08 0001564590-16-014230
us-gaap IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet Income (Loss) from Continuing Operations before Interest Expense, Interest Income, Income Taxes, Noncontrolling Interests, Net USD -8.56M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-10 0000950170-23-041468
us-gaap IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -2.34M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap IncomeLossFromContinuingOperationsPerBasicShare Income (Loss) from Continuing Operations, Per Basic Share USD/shares -1.71 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap IncomeLossFromContinuingOperationsPerDilutedShare Income (Loss) from Continuing Operations, Per Diluted Share USD/shares -1.71 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTax Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD 0 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-07 0001193125-25-272375
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share USD/shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share USD/shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-08 0001564590-16-014230
us-gaap IncomeTaxesPaid Income Taxes Paid USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011019
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 8,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 1.77M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -491,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD -6,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -22,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 8,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD -748,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 200,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap IncreaseDecreaseInContractWithCustomerAsset Increase (Decrease) in Contract with Customer, Asset USD -3,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-31 0001564590-21-017118
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011019
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -351,000 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-07 0001564590-18-028112
us-gaap IncreaseDecreaseInDueFromRelatedParties Increase (Decrease) in Due from Related Parties USD -100,000 2014-01-01 2014-12-31 2015 FY 10-K 2016-03-08 0001564590-16-014230
us-gaap IncreaseDecreaseInDueToRelatedParties Increase (Decrease) in Due to Related Parties USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD -239,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap IncreaseDecreaseInOtherCurrentLiabilities Increase (Decrease) in Other Current Liabilities USD -7,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD 0 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-10 0000950170-23-041468
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -36,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap IncreaseDecreaseInUnbilledReceivables Increase (Decrease) in Unbilled Receivables USD 164,000 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-07 0001564590-18-028112
us-gaap IncrementalCommonSharesAttributableToCallOptionsAndWarrants Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants shares 72,712 2021-01-01 2021-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009747
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap IndefiniteLivedIntangibleAssetsExcludingGoodwill Indefinite-lived Intangible Assets (Excluding Goodwill) USD 40,000 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011019
us-gaap IntangibleAssetsGrossExcludingGoodwill Intangible Assets, Gross (Excluding Goodwill) USD 546,000 2022-09-30 2022 Q3 10-Q 2022-11-10 0000950170-22-024557
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 39,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap InterestExpense Interest Expense USD 1,000 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009747
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 27,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 288,000 2017-01-01 2017-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012544
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038176
us-gaap InterestPayableCurrent Interest Payable, Current USD 0 2017-12-31 2017 FY 10-K 2018-03-20 0001564590-18-006338
us-gaap InventoryNet Inventory, Net USD 973,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap InventoryNoncurrent Inventory, Noncurrent USD 0 2024-12-31 2024 FY 10-K 2025-03-25 0000950170-25-044487
us-gaap InventoryValuationReserves Inventory Valuation Reserves USD 2.30M 2015-12-31 2015 FY 10-K 2016-03-08 0001564590-16-014230
us-gaap InventoryWriteDown Inventory Write-down USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap InvestmentIncomeAmortizationOfPremium Investment Income, Amortization of Premium USD 140,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-08 0001564590-17-003724
us-gaap InvestmentIncomeNetAmortizationOfDiscountAndPremium Investment Income, Net, Amortization of Discount and Premium USD 89,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-20 0001564590-18-006338
us-gaap Investments Investments USD 0 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap InvestmentsFairValueDisclosure Investments, Fair Value Disclosure USD 4.76M 2025-09-30 2025 Q3 10-Q 2025-11-07 0001193125-25-272375
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 93,000 2014-01-01 2014-12-31 2015 FY 10-K 2016-03-08 0001564590-16-014230
us-gaap LeaseCost Lease, Cost USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 155,000 2024-12-31 2024 FY 10-K 2025-03-25 0000950170-25-044487
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 3.40M 2020-12-31 2020 FY 10-K 2021-03-31 0001564590-21-017118
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 155,000 2024-12-31 2024 FY 10-K 2025-03-25 0000950170-25-044487
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 782,000 2020-12-31 2020 FY 10-K 2021-03-31 0001564590-21-017118
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 168,000 2021-12-31 2021 FY 10-K 2022-03-31 0000950170-22-005253
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 156,000 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011019
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 156,000 2023-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038176
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 35,000 2023-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038176
us-gaap LessorOperatingLeaseAssumptionsAndJudgmentsValueOfUnderlyingAssetAmount Lessor, Operating Lease, Assumptions and Judgments, Value of Underlying Asset, Amount USD 86.00M 2025-09-30 2025 Q3 10-Q 2025-11-07 0001193125-25-272375
us-gaap Liabilities Liabilities USD 2.31M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 4.72M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap LiabilitiesCurrent Liabilities, Current USD 1.27M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 8.66M 2018-09-30 2018 Q3 10-Q 2018-11-07 0001564590-18-028112
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 26.72M 2015-03-31 2015 Q1 10-Q 2015-06-25 0001193125-15-233674
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation Disposal Group, Including Discontinued Operation, Liabilities USD 0 2024-03-31 2024 Q1 10-Q 2024-05-13 0000950170-24-058563
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Liabilities, Current USD 0 2024-12-31 2024 FY 10-K 2025-03-25 0000950170-25-044487
us-gaap LicenseCosts License Costs (Deprecated 2018-01-31) USD 0 2014-01-01 2014-12-31 2015 FY 10-K 2016-03-08 0001564590-16-014230
us-gaap LicensesRevenue Licenses Revenue (Deprecated 2018-01-31) USD 106,000 2017-01-01 2017-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012544
us-gaap LongTermDebt Long-term Debt USD 114,000 2021-09-30 2021 Q3 10-Q 2021-11-15 0000950170-21-004634
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 0 2016-12-31 2017 FY 10-K 2018-03-20 0001564590-18-006338
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 36,000 2021-09-30 2021 Q3 10-Q 2021-11-15 0000950170-21-004634
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive Long-Term Debt, Maturity, Year Five USD 29,000 2020-06-30 2020 Q2 10-Q 2020-08-13 0001564590-20-040076
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 1,000 2021-06-30 2021 Q2 10-Q 2021-08-16 0001564590-21-044701
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 30,000 2021-09-30 2021 Q3 10-Q 2021-11-15 0000950170-21-004634
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 39,000 2021-09-30 2021 Q3 10-Q 2021-11-15 0000950170-21-004634
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 9,000 2021-09-30 2021 Q3 10-Q 2021-11-15 0000950170-21-004634
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 0 2021-12-31 2021 FY 10-K 2022-03-31 0000950170-22-005253
us-gaap LongTermInvestments Long-term Investments USD 2.50M 2016-12-31 2017 FY 10-K 2018-03-20 0001564590-18-006338
us-gaap LongTermNotesPayable Notes Payable, Noncurrent USD 130,000 2020-03-31 2020 Q1 10-Q 2020-05-13 0001564590-20-025131
us-gaap MarketableSecuritiesRealizedGainLoss Marketable Securities, Realized Gain (Loss) USD -10.22M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-31 0000950170-22-005253
us-gaap MarketingAndAdvertisingExpense Marketing and Advertising Expense USD 25,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0000950170-25-109040
us-gaap MinorityInterest Stockholders' Equity Attributable to Noncontrolling Interest USD 0 2024-12-31 2024 FY 10-K 2025-03-25 0000950170-25-044487
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 5.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 10.03M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012544
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD 3.88M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012544
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -2.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -2.62M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012544
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -8.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-25 0000950170-25-044487
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -4.49M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009747
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -4.49M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009747
us-gaap NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 Noncash or Part Noncash Acquisition, Fixed Assets Acquired USD 37,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-31 0000950170-22-005253
us-gaap NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest Noncontrolling Interest, Increase from Sale of Parent Equity Interest USD 750,000 2021-01-01 2021-03-31 2021 Q3 10-Q 2021-11-15 0000950170-21-004634
us-gaap NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance Noncontrolling Interest, Increase from Subsidiary Equity Issuance USD 750,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011019
us-gaap NoninterestExpenseOfferingCost Noninterest Expense Offering Cost USD 421,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001193125-26-223990
us-gaap NotesAndLoansReceivableNetCurrent Financing Receivable, after Allowance for Credit Loss, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap NotesAndLoansReceivableNetNoncurrent Financing Receivable, after Allowance for Credit Loss, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap NotesPayable Notes Payable USD 161,000 2020-03-31 2020 Q1 10-Q 2020-05-13 0001564590-20-025131
us-gaap NotesPayableCurrent Notes Payable, Current USD 31,000 2020-03-31 2020 Q1 10-Q 2020-05-13 0001564590-20-025131
us-gaap NotesPayableRelatedPartiesNoncurrent Notes Payable, Related Parties, Noncurrent USD 0 2015-12-31 2015 FY 10-K 2016-03-08 0001564590-16-014230
us-gaap NotesPayableToBankNoncurrent Notes Payable to Bank, Noncurrent USD 25.13M 2016-12-31 2017 FY 10-K 2018-03-20 0001564590-18-006338
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap OperatingExpenses Operating Expenses USD 26.33M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0000950170-21-004634
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -2.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 1.30M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-25 0001564590-20-012875
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 0 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 0 2024-12-31 2024 FY 10-K 2025-03-25 0000950170-25-044487
us-gaap OperatingLeasePayments Operating Lease, Payments USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011019
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 0 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 2.80M 2018-12-31 2018 FY 10-K 2019-04-01 0001564590-19-010452
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 704,000 2018-12-31 2018 FY 10-K 2019-04-01 0001564590-19-010452
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 295,000 2018-12-31 2018 FY 10-K 2019-04-01 0001564590-19-010452
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 497,000 2018-12-31 2018 FY 10-K 2019-04-01 0001564590-19-010452
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 595,000 2018-12-31 2018 FY 10-K 2019-04-01 0001564590-19-010452
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 713,000 2018-12-31 2018 FY 10-K 2019-04-01 0001564590-19-010452
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 1.30M 2018-01-01 2018-12-31 2018 FY 10-K 2019-04-01 0001564590-19-010452
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 115,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment, after Tax USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD -101,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-10 0000950170-22-024557
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD 0 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-08 0000950170-25-066425
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD 1,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-25 0001564590-20-012875
us-gaap OtherComprehensiveIncomeLossTransfersFromHeldToMaturityToAvailableForSaleSecuritiesNetOfTax OCI, Debt Securities, Available-for-Sale, Transfer from Held-to-Maturity, Gain (Loss), before Adjustment, after Tax USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 283,000 2023-03-31 2023 Q1 10-Q 2023-05-15 0000950170-23-022199
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -4.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap OtherRestructuringCosts Other Restructuring Costs USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-04-01 0001564590-19-010452
us-gaap OtherSellingGeneralAndAdministrativeExpense Other Selling, General and Administrative Expense USD 968,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld Other than Temporary Impairment, Credit Losses Recognized in Earnings, Credit Losses on Debt Securities Held USD 0 2020-09-30 2020 Q3 10-Q 2020-11-13 0001564590-20-053848
us-gaap OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities Other than Temporary Impairment Losses, Investments, Available-for-sale Securities USD 0 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-05 0001564590-15-009725
us-gaap PaymentsForProceedsFromInvestments Payments for (Proceeds from) Investments USD -2.50M 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-08 0001564590-16-014230
us-gaap PaymentsOfDebtExtinguishmentCosts Payment for Debt Extinguishment or Debt Prepayment Cost USD 1.13M 2017-01-01 2017-12-31 2018 FY 10-K 2019-04-01 0001564590-19-010452
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 46,000 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-20 0001564590-18-006338
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 1.31M 2018-01-01 2018-09-30 2019 Q3 10-Q 2019-11-06 0001564590-19-041132
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011019
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-25 0000950170-25-044487
us-gaap PaymentsToAcquireLongtermInvestments Payments to Acquire Long-term Investments USD 2.00M 2013-01-01 2014-08-31 2017 FY 10-K 2018-03-20 0001564590-18-006338
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 11.29M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-05 0001564590-15-009725
us-gaap PreferredStockAccretionOfRedemptionDiscount Preferred Stock, Accretion of Redemption Discount USD 2.57M 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-05 0001564590-15-009725
us-gaap PreferredStockLiquidationPreferenceValue Preferred Stock, Liquidation Preference, Value USD 93.54M 2015-03-31 2015 Q1 10-Q 2015-06-25 0001193125-15-233674
us-gaap PreferredStockNoParValue Preferred Stock, No Par Value USD/shares 0 2015-03-31 2015 Q1 10-Q 2015-06-25 0001193125-15-233674
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2015-05-31 2016 FY 10-K 2017-03-08 0001564590-17-003724
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 20.00M 2015-05-31 2016 FY 10-K 2017-03-08 0001564590-17-003724
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2015-12-31 2015 FY 10-K 2016-03-08 0001564590-16-014230
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2015-05-31 2016 FY 10-K 2017-03-08 0001564590-17-003724
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 120,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap ProceedsFromContributedCapital Proceeds from Contributed Capital USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011019
us-gaap ProceedsFromDivestitureOfInterestInJointVenture Proceeds from Divestiture of Interest in Joint Venture USD 3.15M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-31 0000950170-22-005253
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 50.00M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-25 0001564590-20-012875
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 68.23M 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-11 0001193125-15-285644
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 10.00M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-25 0001564590-20-012875
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 45.00M 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-08 0001564590-17-003724
us-gaap ProceedsFromRepaymentsOfNotesPayable Proceeds from (Repayments of) Notes Payable USD 3.11M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-31 0000950170-22-005253
us-gaap ProceedsFromSaleMaturityAndCollectionsOfInvestments Proceeds from Sale, Maturity and Collection of Investments USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011019
us-gaap ProceedsFromSaleOfEquityMethodInvestments Proceeds from Sale of Equity Method Investments USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-25 0000950170-25-044487
us-gaap ProceedsFromSaleOfIntangibleAssets Proceeds from Sale of Intangible Assets USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap ProceedsFromSaleOfOtherInvestments Proceeds from Sale of Other Investments USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 7,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011019
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011019
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -8.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 1.91M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap RealizedInvestmentGainsLosses Realized Investment Gains (Losses) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap ReclassificationsOfTemporaryToPermanentEquity Reclassifications of Temporary to Permanent Equity USD -48.78M 2014-01-01 2014-12-31 2015 Q3 10-Q 2015-11-05 0001564590-15-009725
us-gaap ReductionOfShortTermCapitalLeaseObligations Reduction of Short-term Capital Lease Obligations USD 72,000 2014-01-01 2014-12-31 2015 FY 10-K 2016-03-08 0001564590-16-014230
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011019
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 8.00M 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-08 0001564590-17-003724
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 2.00M 2020-12-31 2021 FY 10-K 2022-03-31 0000950170-22-005253
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminated Restructuring and Related Cost, Number of Positions Eliminated Position 23 2016-01-01 2016-12-31 2018 FY 10-K 2019-04-01 0001564590-19-010452
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -290.11M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 4.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 1.02M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-07 0001564590-18-028112
us-gaap RevenueFromRelatedParties Revenue from Related Parties USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-08 0001564590-17-003724
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 22.20M 2021-06-01 2021-06-30 2022 FY 10-K 2023-03-30 0000950170-23-011019
us-gaap SalesRevenueGoodsNet Sales Revenue, Goods, Net (Deprecated 2018-01-31) USD 61,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012544
us-gaap SalesRevenueNet Revenue, Net (Deprecated 2018-01-31) USD 214,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012544
us-gaap SegmentReportingOtherItemAmount SegmentReportingOtherItemAmount USD 4.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 4.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 43,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 140,004 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 17.55 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 12.43M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 2,655 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 3,415 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 53,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 3.2 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 226,893 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 11.4 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 2.25M 2016-06-30 2016 Q2 10-Q 2016-08-09 0001564590-16-023753
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 2.85M 2016-06-30 2016 Q2 10-Q 2016-08-09 0001564590-16-023753
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 3.58 2016-06-30 2016 Q2 10-Q 2016-08-09 0001564590-16-023753
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 215,790 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 11.9 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 2.20M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-25 0001564590-20-012875
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 2.81 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 21.95 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 2.95 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 0.45 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap SharePrice Share Price USD/shares 4.31 2025-06-30 2025 FY 10-K/A 2026-04-30 0001193125-26-197315
us-gaap ShortTermInvestments Short-term Investments USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 6.22M 2024-12-31 2024 FY 10-K 2025-03-25 0000950170-25-044487
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 2.40M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.05 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-25 0001564590-20-012875
us-gaap StockIssued1 Stock Issued USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011019
us-gaap StockIssuedDuringPeriodSharesReverseStockSplits Stock Issued During Period, Shares, Reverse Stock Splits shares 19,118 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-25 0000950170-25-044487
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 5,691 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 432,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-31 0001564590-21-017118
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 85.45M 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-08 0001564590-17-003724
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 1,000 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 1,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-09 0001564590-18-012544
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 3.12M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001193125-26-223990
us-gaap StockRepurchasedAndRetiredDuringPeriodValue Stock Repurchased and Retired During Period, Value USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-20 0001564590-18-006338
us-gaap StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased shares 632 2015-12-31 2017 FY 10-K 2018-03-20 0001564590-18-006338
us-gaap TemporaryEquityAccretionToRedemptionValue Temporary Equity, Accretion to Redemption Value USD -2.57M 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-08 0001564590-17-003724
us-gaap TemporaryEquityAccretionToRedemptionValueAdjustment Temporary Equity, Accretion to Redemption Value, Adjustment USD 2.57M 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-08 0001564590-17-003724
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 82.88M 2014-12-31 2015 FY 10-K 2016-03-08 0001564590-16-014230
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 130.04M 2014-12-31 2015 FY 10-K 2016-03-08 0001564590-16-014230
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 105.14M 2014-12-31 2015 FY 10-K 2016-03-08 0001564590-16-014230
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 32.97M 2014-12-31 2015 FY 10-K 2016-03-08 0001564590-16-014230
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 103.36M 2014-12-31 2015 FY 10-K 2016-03-08 0001564590-16-014230
us-gaap UnbilledReceivablesCurrent Unbilled Receivables, Current USD 3,000 2018-12-31 2019 FY 10-K 2020-03-25 0001564590-20-012875
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD -4.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap UnrealizedGainLossOnSecurities Unrealized Gain (Loss) on Securities USD 10.20M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0000950170-21-004634
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities Unrecognized Tax Benefits, Increase Resulting from Settlements with Taxing Authorities USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 2.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126238
us-gaap VariableInterestEntityActivityBetweenVIEAndEntityExpense Variable Interest Entity, Measure of Activity, Expense USD 454,000 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-13 0001564590-20-053848
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 3.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 21.28M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-31 0000950170-22-005253
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 3.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458412

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →